Hepion Pharmaceuticals Stock Market Value
| HEPA Stock | USD 0.66 0.03 4.35% |
| Symbol | Hepion |
Hepion Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Return On Assets (0.93) | Return On Equity (1.90) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hepion Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hepion Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hepion Pharmaceuticals.
| 09/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in Hepion Pharmaceuticals on September 25, 2024 and sell it all today you would earn a total of 0.00 from holding Hepion Pharmaceuticals or generate 0.0% return on investment in Hepion Pharmaceuticals over 60 days. Hepion Pharmaceuticals is related to or competes with Enveric Biosciences, Elevation Oncology, Ocean Biomedical, and Zura Bio. Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chro... More
Hepion Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hepion Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hepion Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 33.54 | |||
| Value At Risk | (8.11) | |||
| Potential Upside | 8.06 |
Hepion Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hepion Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hepion Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Hepion Pharmaceuticals historical prices to predict the future Hepion Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.15) |
Hepion Pharmaceuticals Backtested Returns
Hepion Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0285, which attests that the entity had a -0.0285% return per unit of risk over the last 3 months. Hepion Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hepion Pharmaceuticals' Market Risk Adjusted Performance of (0.14), risk adjusted performance of (0.02), and Standard Deviation of 5.52 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.26, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Hepion Pharmaceuticals will likely underperform. At this point, Hepion Pharmaceuticals has a negative expected return of -0.16%. Please make sure to check out Hepion Pharmaceuticals' value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Hepion Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.54 |
Modest predictability
Hepion Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Hepion Pharmaceuticals time series from 25th of September 2024 to 25th of October 2024 and 25th of October 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hepion Pharmaceuticals price movement. The serial correlation of 0.54 indicates that about 54.0% of current Hepion Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Hepion Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Hepion Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hepion Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Hepion Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Hepion Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hepion Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hepion Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hepion Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hepion Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Hepion Pharmaceuticals Lagged Returns
When evaluating Hepion Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hepion Pharmaceuticals stock have on its future price. Hepion Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hepion Pharmaceuticals autocorrelation shows the relationship between Hepion Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Hepion Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:Check out Hepion Pharmaceuticals Correlation, Hepion Pharmaceuticals Volatility and Hepion Pharmaceuticals Alpha and Beta module to complement your research on Hepion Pharmaceuticals. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Hepion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.